Patients with SLE have an ongoing IFN-α production, which gives rise to the IFN signature that can be demonstrated in approximately 50 % of adult SLE patients and the majority of children with SLE [9]. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.